Argentine Foundation Requests Government Reject Patent Request For HIV Drug Made By Gilead

SciDev.Net: Argentine NGO objects to antiretroviral patent request
“An Argentine foundation has asked the National Institute of Industrial Property (INPI) to deny a patent request for an antiretroviral drug by the North American pharmaceutical company Gilead Sciences Inc. … In Brazil the same request by Gilead was rejected in 2017…” (De Ambrosio, 3/19).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.